Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTotally Regulatory News (TLY)

  • This share is currently suspended. It was suspended at a price of 0.25
  • There is currently no data for TLY

Winning Two Industry Awards

28 Nov 2014 07:00

RNS Number : 1824Y
Totally PLC
28 November 2014
 



28 November 2014

 

Totally Plc

("Totally" or "the Company")

 

Winning Two Industry Awards Underlines Value of Totally's Service

 

 

Totally (AIM: TLY) announces that Totally Health Ltd ("Totally Health"), the Company's wholly owned subsidiary and the provider of a range of services to the healthcare sector,has been named as winners of the Pharmaceutical Market Excellence Awards (PMEA) 2014 for Excellence in Healthcare Partnership and the 2014 General Practice Award for Clinical Team of the Year - Respiratory.

 

Both these awards were won in collaboration with the Leicester City TotalCare Project which was also a finalist in the General Practice Award for Team award for Innovators of the Year.

 

The Leicester City TotalCare service has utilised real-time communication systems to support patient well-being and health improvement in patients with chronic obstructive pulmonary disease (COPD). This is the first demonstration in the UK of integrating health coaching, telehealth and respiratory nurse expertise, to deliver a single model of care with the patient experience at the centre.

 

Wendy Lawrence, Totally CEO, commented:

 

"I am thrilled that Totally Health has won these awards which reflect the excellent services we are delivering to the NHS.

 

"Recognition of this type highlights the value of Totally's offering and gives me great confidence that we will continue to deliver on our new business pipeline. Thereby changing the lives of people living with a Long Term Condition such as COPD and delivering value for our shareholders"

 

The Judges said:

 

"This entry contains all of the elements that will shape the future management of chronic conditions; technology, collaboration and innovative processes. It reshaped the care pathway and reduced hospitalisations. It is scalable, transferable and will be a model for other commissioners. The NHS need the benefits this entry provides."

 

 

 

For further information contact:

Totally Plc / Totally Health

 020 3077 2202

Wendy Lawrence, Chief Executive

Allenby Capital Limited (Nominated Adviser & Joint Broker)

 0203 328 5656

Nick Naylor / Nick Athanas

Optiva Securities Limited (Joint Broker)

020 3137 1902

Christian Dennis / Jeremy King

Blytheweigh

020 7138 3203

Tim Blythe / Camilla Horsfall

 

 

Notes to Editors

Totally plc is focused on the provision of professional health coaching which promotes and facilitates self care. Totally's services have been shown to reduce costs for Clinical Commissioning Groups by, for example, reducing unplanned admissions to hospitals and visits to Accident and Emergency Departments.

 

Totally currently operates contracts with NHS England and several CCGs across England delivering their Long Term Condition Management and Shared Decision Making Programs.

 

Totally Health is a provider of a range of services to the healthcare sector that supports individuals to better understand their clinical conditions and support them to avoid exacerbations of such conditions and promote self care.

 

Shared Decision Making and the Management of Long Term Conditions are key strategic areas for the NHS in England. The NHS in England estimates that £7 out of every £10 spent on health and social care is spent looking after people diagnosed with a Long Term Condition.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAPGGBWGUPCGGM
Date   Source Headline
7th Jul 20257:00 amRNSCancellation - Totally Plc
9th Jun 20257:00 amRNSAdministration and Director Resignations
6th Jun 20251:00 pmRNSIntention to Appoint Administrators and Suspension
6th Jun 20251:00 pmRNSSuspension - Totally plc
30th May 20252:25 pmRNSHolding(s) in Company
29th May 20252:10 pmRNSHolding(s) in Company
23rd May 20257:00 amRNSUpdate on Strategic Review
2nd May 20257:00 amRNSHolding(s) in Company
1st May 20257:00 amRNSCommencement of Strategic Review
1st May 20257:00 amRNSTrading Update
27th Mar 20257:00 amRNSDirector/PDMR Shareholding
25th Mar 20253:35 pmRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
5th Mar 20253:15 pmRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
3rd Mar 20259:00 amRNSHolding(s) in Company
28th Feb 20257:00 amRNSHolding(s) in Company
27th Feb 20257:00 amRNSContract Renewals
26th Feb 20251:00 pmRNSHolding(s) in Company
25th Feb 20256:00 pmRNSHolding(s) in Company
25th Feb 202511:00 amRNSHolding(s) in Company
21st Feb 20257:00 amRNSDirectorate Change
20th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20257:00 amRNSOutlook Update
13th Jan 20257:00 amRNSDirectorate Change
7th Jan 20254:15 pmRNSHolding(s) in Company
3rd Dec 20244:00 pmRNSHolding(s) in Company
6th Nov 20247:00 amRNSInterim Results
5th Nov 20245:00 pmRNSHolding(s) in Company
31st Oct 20247:00 amRNSUpdate on Banking Facility
17th Oct 20247:00 amRNSNotice of Interim Results & Investor Presentation
27th Sep 20245:45 pmRNSResult of AGM
27th Sep 20249:00 amRNSAGM Statement
27th Sep 20247:00 amRNSContract Win and Extension
20th Sep 20242:30 pmRNSHolding(s) in Company
10th Sep 20247:00 amRNSDirector/PDMR Shareholding
4th Sep 20241:30 pmRNSPosting of Annual Report and Notice of AGM
4th Sep 20247:00 amRNSDirector/PDMR Shareholding
29th Aug 20247:00 amRNSContract Wins
27th Aug 20246:16 pmRNSHolding(s) in Company
27th Aug 20246:13 pmRNSHolding(s) in Company
2nd Aug 20249:30 amRNSHolding(s) in Company
2nd Aug 20247:00 amRNSDirectorate Change
1st Aug 202410:45 amRNSHolding(s) in Company
24th Jul 20247:00 amRNSDirectorate Change
24th Jul 20247:00 amRNSPreliminary results
23rd Jul 20247:00 amRNSContract extensions and win
22nd Jul 20243:30 pmRNSHolding(s) in Company
18th Jul 20247:00 amRNSNotice of Results
11th Jul 20247:00 amRNSContract extensions

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.